170 related articles for article (PubMed ID: 29258912)
21. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
Dimitrijevic D; Shaw AJ; Florence AT
J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
[TBL] [Abstract][Full Text] [Related]
22. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers.
Lucarini S; Fagioli L; Cavanagh R; Liang W; Perinelli DR; Campana M; Stolnik S; Lam JKW; Casettari L; Duranti A
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29970849
[TBL] [Abstract][Full Text] [Related]
24. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Properties of Sucrose- and Lactose-Based Aromatic Ester Surfactants as Potential Drugs Permeability Enhancers.
Verboni M; Perinelli DR; Qiu CY; Tiboni M; Aluigi A; Lucarini S; Lam JKW; Duranti A
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259370
[TBL] [Abstract][Full Text] [Related]
26.
Cuellar P; Hernández-Nava E; García-Rivera G; Chávez-Munguía B; Schnoor M; Betanzos A; Orozco E
Front Cell Infect Microbiol; 2017; 7():372. PubMed ID: 28861400
[TBL] [Abstract][Full Text] [Related]
27. In silico modelling of permeation enhancement potency in Caco-2 monolayers based on molecular descriptors and random forest.
Welling SH; Clemmensen LK; Buckley ST; Hovgaard L; Brockhoff PB; Refsgaard HH
Eur J Pharm Biopharm; 2015 Aug; 94():152-9. PubMed ID: 26004819
[TBL] [Abstract][Full Text] [Related]
28. The effect of phospholipids and fatty acids on tight-junction permeability and bacterial translocation.
Sawai T; Drongowski RA; Lampman RW; Coran AG; Harmon CM
Pediatr Surg Int; 2001 May; 17(4):269-74. PubMed ID: 11409160
[TBL] [Abstract][Full Text] [Related]
29. Effect of Variations in the Fatty Acid Residue of Lactose Monoesters on Their Emulsifying Properties and Biological Activities.
Liang MY; Banwell MG; Wang Y; Lan P
J Agric Food Chem; 2018 Nov; 66(47):12594-12603. PubMed ID: 30395455
[TBL] [Abstract][Full Text] [Related]
30. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
31. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.
McCartney F; Perinelli DR; Tiboni M; Cavanagh R; Lucarini S; Filippo Palmieri G; Casettari L; Brayden DJ
Int J Pharm; 2021 May; 601():120593. PubMed ID: 33857587
[TBL] [Abstract][Full Text] [Related]
32. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.
Sha X; Yan G; Wu Y; Li J; Fang X
Eur J Pharm Sci; 2005 Apr; 24(5):477-86. PubMed ID: 15784337
[TBL] [Abstract][Full Text] [Related]
33. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
34. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
35. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
36. Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability.
Konishi Y; Hagiwara K; Shimizu M
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2449-57. PubMed ID: 12506986
[TBL] [Abstract][Full Text] [Related]
37. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
38. Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Lin H; Gebhardt M; Bian S; Kwon KA; Shim CK; Chung SJ; Kim DD
Int J Pharm; 2007 Feb; 330(1-2):23-31. PubMed ID: 16997520
[TBL] [Abstract][Full Text] [Related]
39. The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers.
McGilligan VE; Wallace JM; Heavey PM; Ridley DL; Rowland IR
Food Chem Toxicol; 2007 Sep; 45(9):1593-8. PubMed ID: 17399881
[TBL] [Abstract][Full Text] [Related]
40. The effect of monomers and of micellar and vesicular forms of non-ionic surfactants (Solulan C24 and Solulan 16) on Caco-2 cell monolayers.
Dimitrijevic D; Lamandin C; Uchegbu IF; Shaw AJ; Florence AT
J Pharm Pharmacol; 1997 Jun; 49(6):611-6. PubMed ID: 9330201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
